When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes

Haematologica. 2013 Mar;98(3):323-4. doi: 10.3324/haematol.2013.086231.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Bone Marrow Cells / metabolism
  • Bone Marrow Transplantation* / adverse effects
  • Bone Marrow Transplantation* / economics
  • Bone Marrow Transplantation* / legislation & jurisprudence
  • Humans
  • Ischemia / therapy*
  • Syndrome